Websites, domains, hosts that links to astellaspharmasupportsolutions.com
Our database shows, that the website astellaspharmasupportsolutions.com is linked by a total of 4 websites.
Number of websites/domains displayed: 4
Results found: 4
Websites discovered:
Metastatic CR Prostate Cancer Treatment - XTANDI® (enzalutamide)http://pageoverview.com/website-report/xtandihcp.com
Learn about XTANDI® (enzalutamide) capsules indicated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
- Expected expiration: July 10th in 2018
- Creation date: July 10th in 2012
- Renew date: July 1st in 2015
Astellas Pharma US, Inc. | Unsubscribehttp://pageoverview.com/website-report/astellasunsubscribe.com
- Expected expiration: December 7th in 2020
- Creation date: December 7th in 2011
- Renew date: November 10th in 2017
Overactive Bladder Medication | Myrbetriq (mirabegron)http://pageoverview.com/website-report/myrbetriq.com
Myrbetriq is an FDA-approved treatment for overactive bladder (OAB) with symptoms of urgency, frequency and leakage in adults. Learn about Myrbetriq.
- Expected expiration: April 10th in 2022
- Creation date: April 10th in 2012
- Renew date: October 22nd in 2014
Overactive Bladder Medication | VESIcare® (solifenacin succinate)http://pageoverview.com/website-report/vesicare.com
VESIcare is used for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and leakage.
- Expected expiration: November 1st in 2017
- Creation date: November 1st in 2002
- Renew date: October 21st in 2014